Studies of drug-induced lichenoid reactions: Criteria for case selection

Oral Diseases

Volumn 9, Issue 4, 2003, Pages 163-164

  McCartan, B E ^a   McCreary, C E ^b   Healy, C M ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMALGAM; ANTIHYPERTENSIVE AGENT; CYTOCHROME P450; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT;

COHORT ANALYSIS; DATA ANALYSIS; DRUG EFFECT; DRUG ERUPTION; DRUG METABOLISM; EDITORIAL; HISTOPATHOLOGY; HUMAN; IMMUNOLOGY; LICHENOID ERUPTION; METHODOLOGY; MOUTH DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLICATION; SAMPLING;

HUMANS; LICHEN PLANUS, ORAL; LICHENOID ERUPTIONS; PATIENT SELECTION; RESEARCH DESIGN;

EID: 0038045262     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1601-0825.2003.03970.x     Document Type: Editorial

References (8)

1. Andreasen JO (1968). Oral lichen planus: 1. A clinical evaluation of 115 cases. Oral Surg Oral Med Oral Pathol 25: 31-42.
2. Camisa C, Allen CM, Bowen B, Olsen RG (1986). Indirect immunofluorescence of oral lichen planus. J Oral Pathol 15: 218-220.
3. Lamey P-J, McCartan BE, Macdonald DG, MacKie M (1995). Basal cell cytoplasmic autoantibodies in oral lichenoid reactions. Oral Surg Oral Med Oral Pathol 79: 44-49.
4. McCartan BE, McCreary CE (1997). Oral lichenoid drug eruptions. Oral Dis 3: 58-63.
5. McCartan BE, McCreary CE (1999). What is the rationale for treating oral lichen planus? Oral Dis 5: 181-182.
6. Pennys NS, Ackerman AB, Gotlieb NL (1974). Gold dermatitis, a clinical and histopathological study. Arch Dermatol 109: 372-376.
7. Potts AJC, Hamburger J, Scully C (1987). The medication of patients with oral lichen planus and the association of nonsteroidal anti-inflammatory drugs with erosive lesions. Oral Surg Oral Med Oral Pathol 64: 541-543.
8. Rietschel RL, Fowler JF (1995). Fisher's contact dermatitis, 4th edn. Williams and Wilkins: Baltimore, p. 141.